Comparative effect of sufentanil and dexmedetomidin on myoclonus incidence and pain induced by anesthesia with etomidate

Comparative effect of sufentanil and dexmedetomidin on myoclonus incidence and pain induced by anesthesia with etomidate: a double blin clinical trial study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20101211005362N25

Enrollment

108

Registered

2020-07-30

Start date

2018-07-21

Completion date

Unknown

Last updated

2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pain. premedication anesthetic

Interventions

Intervention 1: In the present study, there are two intervention groups and one control group. 1- In the first intervention group, sufentanil is injected intravenously at the rate of 0.1 micrograms pe

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients 18 to 60 years ASA Class 1 and 2 Candidate for surgery and in need of general anesthesia Agree to participate in the study

Exclusion criteria

Exclusion criteria: heart and liver failure, mental illness, neurological diseases, opioid allergy Drug addiction

Design outcomes

Primary

Measure	Time frame
Myoclonus. Timepoint: Minutes 0 - 5 - 10 - 15 - 30 - 60 - 60 after atomiditis injection. Method of measurement: Pulse oximeter.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammadreza Safavi

Esfahan University of Medical Sciences

safavi@med.mui.ac.ir+98 31 1273 2659

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026